Ramaswamy Govindan

96.7k total citations · 6 hit papers
482 papers, 18.1k citations indexed

About

Ramaswamy Govindan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ramaswamy Govindan has authored 482 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 294 papers in Pulmonary and Respiratory Medicine, 290 papers in Oncology and 121 papers in Molecular Biology. Recurrent topics in Ramaswamy Govindan's work include Lung Cancer Treatments and Mutations (261 papers), Lung Cancer Research Studies (170 papers) and Lung Cancer Diagnosis and Treatment (113 papers). Ramaswamy Govindan is often cited by papers focused on Lung Cancer Treatments and Mutations (261 papers), Lung Cancer Research Studies (170 papers) and Lung Cancer Diagnosis and Treatment (113 papers). Ramaswamy Govindan collaborates with scholars based in United States, France and United Kingdom. Ramaswamy Govindan's co-authors include Daniel Morgensztern, Janakiraman Subramanian, Feng Gao, William L. Read, Jay F. Piccirillo, Ryan M. Tierney, Nathan Page, Siddhartha Devarakonda, Edward L. Spitznagel and Anna Vlahiotis and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Ramaswamy Govindan

457 papers receiving 17.7k citations

Hit Papers

Changing Epidemiology of Small-Cell Lung Cancer in the Un... 2006 2026 2012 2019 2006 2020 2007 2015 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
    2006 1.5k citations Ramaswamy Govindan, Daniel Morgensztern et al. Journal of Clinical Oncology profile →
  2. Sex and gender: modifiers of health, disease, and medicine
    2020 1.2k citations Ramaswamy Govindan et al. profile →
  3. Lung Cancer in Never Smokers: A Review
    2007 484 citations Ramaswamy Govindan et al. Journal of Clinical Oncology profile →
  4. Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study
    2015 430 citations Ramaswamy Govindan, Alexander I. Spira et al. Journal of Clinical Oncology profile →
  5. Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
    2010 420 citations Daniel Morgensztern, Ramaswamy Govindan et al. profile →
  6. Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
    2013 370 citations Ramaswamy Govindan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramaswamy Govindan United States 65 9.8k 9.1k 5.2k 2.9k 2.1k 482 18.1k
Yutaka Nishiwaki Japan 61 14.7k 1.5× 13.4k 1.5× 4.8k 0.9× 2.4k 0.8× 2.3k 1.1× 272 21.2k
Primo N. Lara United States 60 8.5k 0.9× 7.0k 0.8× 6.0k 1.2× 3.5k 1.2× 1.0k 0.5× 458 16.3k
Harry J.M. Groen Netherlands 70 12.3k 1.3× 8.8k 1.0× 4.8k 0.9× 3.0k 1.0× 1.6k 0.8× 557 20.2k
John J. Crowley United States 59 8.8k 0.9× 8.0k 0.9× 3.9k 0.7× 1.8k 0.6× 1.5k 0.7× 195 17.8k
David H. Johnson United States 51 9.3k 1.0× 14.3k 1.6× 4.9k 1.0× 1.8k 0.6× 4.3k 2.0× 241 20.2k
John R. Mackey Canada 84 4.6k 0.5× 14.8k 1.6× 5.9k 1.1× 4.0k 1.4× 1.3k 0.6× 335 24.6k
Kathy S. Albain United States 61 9.2k 0.9× 11.9k 1.3× 2.9k 0.6× 3.8k 1.3× 821 0.4× 234 19.1k
Bella Kaufman Israel 54 3.7k 0.4× 8.1k 0.9× 4.4k 0.8× 3.2k 1.1× 1.1k 0.5× 250 15.2k
Marianne Paesmans Belgium 57 4.3k 0.4× 7.9k 0.9× 2.3k 0.5× 2.2k 0.8× 1.7k 0.8× 337 13.0k
Corey J. Langer United States 73 16.9k 1.7× 17.1k 1.9× 5.7k 1.1× 3.1k 1.1× 2.0k 0.9× 563 28.2k

Countries citing papers authored by Ramaswamy Govindan

Since Specialization
Citations

This map shows the geographic impact of Ramaswamy Govindan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramaswamy Govindan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramaswamy Govindan more than expected).

Fields of papers citing papers by Ramaswamy Govindan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramaswamy Govindan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramaswamy Govindan. The network helps show where Ramaswamy Govindan may publish in the future.

Co-authorship network of co-authors of Ramaswamy Govindan

This figure shows the co-authorship network connecting the top 25 collaborators of Ramaswamy Govindan. A scholar is included among the top collaborators of Ramaswamy Govindan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramaswamy Govindan. Ramaswamy Govindan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ireland, Abbie S., M. Weber, L. Zuo, et al.. (2025). Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer. Nature. 647(8088). 257–267. 4 indexed citations
2.
Safi, Mohammed, Fred R. Hirsch, Shun Lu, et al.. (2025). Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions. Nature Reviews Clinical Oncology. 22(3). 200–214. 10 indexed citations
3.
Li, Bob T., Jeffrey Clarke, Enriqueta Felip, et al.. (2024). Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial.. Journal of Clinical Oncology. 42(16_suppl). 8512–8512. 8 indexed citations
4.
Wang, Xiaoyan, Xiaoyu Zong, Jingqin Luo, et al.. (2023). Sleep Behaviors, Genetic Predispositions, and Risk of Esophageal Cancer. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1079–1086. 5 indexed citations
5.
Contreras, J., Pamela Samson, T.A. DeWees, et al.. (2022). Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 113(4). 742–748. 11 indexed citations
6.
Barnell, Erica K., Adam Waalkes, Kelsi Penewit, et al.. (2019). Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. JCO Clinical Cancer Informatics. 3(3). 1–12. 6 indexed citations
7.
Morgensztern, Daniel, Benjamin Besse, Laurent Greillier, et al.. (2019). Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. Clinical Cancer Research. 25(23). 6958–6966. 229 indexed citations
8.
Devarakonda, Siddhartha, Sumithra Sankararaman, Brett H. Herzog, et al.. (2019). Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical Cancer Research. 25(20). 6119–6126. 41 indexed citations
9.
Bahleda, Rastislav, Antoîne Italiano, Cinta Hierro, et al.. (2019). Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors. Clinical Cancer Research. 25(16). 4888–4897. 187 indexed citations
10.
Vicent, Silvestre, Naiara Perurena, Ramaswamy Govindan, & Fernando Lecanda. (2015). Bone Metastases in Lung Cancer. Potential Novel Approaches to Therapy. American Journal of Respiratory and Critical Care Medicine. 192(7). 799–809. 26 indexed citations
11.
Govindan, Ramaswamy & C. Chinnusamy. (2014). Tillage, crop establishment and weed management in rice under conservation agriculture system. Indian Journal of Weed Science. 46(2). 117–122. 4 indexed citations
12.
Yin, Yongjun, et al.. (2013). Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3. Cancer Research. 73(18). 5730–5741. 46 indexed citations
13.
Govindan, Ramaswamy, et al.. (2010). Studies on the performance of castor genotypes on rearing cocoon of eri silkworm.. INTERNATIONAL JOURNAL OF PLANT PROTECTION. 3(2). 219–224. 1 indexed citations
14.
Natale, Ronald B., David Bodkin, Ramaswamy Govindan, et al.. (2009). Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study. Journal of Clinical Oncology. 27(15). 2523–2529. 194 indexed citations
15.
Clamon, Gerald H., James E. Herndon, Jeffrey A. Kern, et al.. (2005). Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb‐B2. Cancer. 103(8). 1670–1675. 93 indexed citations
16.
Govindan, Ramaswamy, et al.. (2000). Influence of nitrogenous source fertilizers on yield and foliar constituents of rainfed mulberry.. Mysore Journal of Agricultural Sciences. 34(2). 147–152.
17.
Govindan, Ramaswamy, et al.. (2000). Performance of bivoltine x multivoltine cross breeds of silkworm for cocoon and silk traits.. Indian Journal of Sericulture. 39(2). 169–171. 1 indexed citations
18.
Rajanna, B., et al.. (2000). Influence of sericulture byproducts and other organic manures on grainage parameters of silkworm (Bombyx mori L.).. Mysore Journal of Agricultural Sciences. 34(1). 11–15.
19.
Govindan, Ramaswamy & D C Ihde. (1997). PRACTICAL ISSUES IN THE MANAGEMENT OF THE PATIENT WITH SMALL CELL LUNG CANCER. Chest Surgery Clinics of North America. 7(1). 167–181. 1 indexed citations
20.
Govindan, Ramaswamy, et al.. (1990). Influence of pupal weight in multivoltine silkworm, Bombyx mori L. on some metric parameters.. Mysore Journal of Agricultural Sciences. 24(4). 499–502. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaka Nishiwaki Breakdown of academic impact, for papers by Primo N. Lara Breakdown of academic impact, for papers by Harry J.M. Groen Breakdown of academic impact, for papers by John J. Crowley Breakdown of academic impact, for papers by David H. Johnson Breakdown of academic impact, for papers by John R. Mackey Breakdown of academic impact, for papers by Kathy S. Albain Breakdown of academic impact, for papers by Bella Kaufman Breakdown of academic impact, for papers by Marianne Paesmans Breakdown of academic impact, for papers by Corey J. Langer
Rankless by CCL
2026